Vita Therapeutics: Funding, Investors & Team (Oct 2026)
Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Vita utilizes induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita works towards delivering tissue-specific stem cells that have the capability to continue to replicate and support muscle regeneration. The company's lead therapy, VTA-110, is a potential allogenic iPSC-based therapy that has shown the ability to repair and regenerate healthy muscle in preclinical studies and has the potential to benefit patients with LGMD and other muscular dystrophies.
Vita Therapeutics has raised $63.0M across 2 funding rounds on record, the most recent a Series B of $31.0M announced in Oct 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vita Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2022.
Vita Therapeutics Funding Rounds
Vita Therapeutics raised $32.0M in an undisclosed round announced in Jun 2021.
1.3 years later, a Series B of $31.0M was announced in Oct 2022.
Vita Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Vita Therapeutics Funding Compared to Other Biotechnology Startups
Vita Therapeutics' latest round of $31.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vita Therapeutics in Biotechnology and Baltimore
Companies Similar to Vita Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Vita Therapeutics Funding FAQs
What does Vita Therapeutics do?
Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Vita utilizes induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita works towards delivering tissue-specific stem cells that have the capability to continue to replicate and support muscle regeneration. The company's lead therapy, VTA-110, is a potential allogenic iPSC-based therapy that has shown the ability to repair and regenerate healthy muscle in preclinical studies and has the potential to benefit patients with LGMD and other muscular dystrophies.
How much funding has Vita Therapeutics raised?
Vita Therapeutics has raised $63.0M across 2 rounds on record. The most recent is a Series B of $31.0M announced in Oct 2022.
When did Vita Therapeutics last raise funding?
Vita Therapeutics' most recent funding round on record is a Series B of $31.0M, announced in Oct 2022.
Who is the CEO of Vita Therapeutics?
Douglas Falk is listed as CEO at Vita Therapeutics.
Where is Vita Therapeutics headquartered?
Vita Therapeutics is based in Baltimore, Maryland, United States.
How many employees does Vita Therapeutics have?
Vita Therapeutics is in the 1-10 employee band.
How does Vita Therapeutics' funding compare to other Biotechnology startups?
Vita Therapeutics' latest round of $31.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Vita Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vita Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.